Sanofi S.A. (SAN)
SIX
Closed
Aug 21, 2026
Day's Range
71.8052 wk Range
71.80Overview - SAN - Sanofi S.A.
Key Statistics
Valuation
Enterprise Value
96.93B
P/E (Trailing)
‪23.77‬
Price / Book
‪1.23‬
EV / EBITDA
‪7.65‬
Profitability
Gross Margin
‪75.47%‬
Profit Margin
‪8.09%‬
Operating Margin
‪21.03%‬
Return on Assets
‪5.09%‬
Return on Equity
‪5.70%‬
Ownership
Shares Outstanding
1.21B
Float
1.08B
Held by Insiders
‪10.31%‬
Held by Institutions
‪42.84%‬
Price stats
Beta
‪0.27‬
Dividends
Payout Ratio
‪0.00%‬
Frequency
Annual
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - SAN - Sanofi S.A.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on SIX.
- SANSIXSanofi S.A.-1.95%52-week change23.62P/E (Trailing)‪8.09%‬Profit Margin
- LLYSIXEli Lilly and Company+44.06%52-week change42.12P/E (Trailing)‪33.52%‬Profit Margin
- JNJSIXJohnson & Johnson+20.88%52-week change30.19P/E (Trailing)‪21.48%‬Profit Margin
- ROPSIXRoche Holding AG+29.76%52-week change24.76P/E (Trailing)‪19.60%‬Profit Margin
- MRKSIXMerck & Co., Inc.+32.03%52-week change32.58P/E (Trailing)‪13.58%‬Profit Margin
- NOVNEESIXNovartis AG+20.72%52-week change22.70P/E (Trailing)‪22.50%‬Profit Margin
- BMYSIXBristol-Myers Squibb Company+20.42%52-week change14.41P/E (Trailing)‪18.87%‬Profit Margin
Profile Summary - SAN - Sanofi S.A.
About
Sanofi S.A. is a French biopharmaceutical company headquartered in Paris. Sanofi focuses on the research, development, manufacturing, and commercialization of medicines and vaccines for patients worldwide. Its current business is organized around specialty care, vaccines, and general medicines, with products spanning…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
